Verisk Health appoints former boss of Accretive Health as CEO

Verisk Health, a leader in data-driven healthcare solutions, has appointed Emad Rizk, the former head of Accretive Health, as its chief executive officer (CEO).

Rizk has over 25 years of experience in the healthcare industry, who worked closely with Payers and Government entities. Prior to Verisk Health, Rizk served as CEO at Accretive Health and was a member of its Board of Directors.

Before Accretive Health, he was president at McKesson Health Solutions, a business that provides clinical and financial solutions to the Healthcare payers. He is also a regular lecturer at Wharton, Harvard, MIT, Columbia, and Kellogg.

“Dr. Emad Rizk has a long and successful track record in the healthcare industry with relevant Payer experience leading businesses like Verisk Health,” said Ramzi Musallam, owner of Verisk Health, as well as CEO and Managing Partner at Veritas Capital.

“He shares our vision of delivering the strongest value proposition to customers through innovation and outstanding service. We are confident in his ability to drive the Company forward as we move into a new chapter as a standalone business focused on proprietary data analytics in key vertical markets.”

Rizk added: “I am honored by the opportunity to serve as CEO of this exceptional analytics company. Verisk Health is one of the most respected analytics organizations in the healthcare industry. As commercial Payers and Government entities explore ways to improve performance and lower costs, I believe Verisk Health is well positioned to be their partner of choice.

“I look forward to leveraging my Payer experience and working closely with our talented team and valued partners at Veritas Capital to maintain the company’s strong culture and momentum. We are a high growth organization committed to solidifying our identity and leadership as a standalone company and to advancing and innovating our data services, analytics, and technologies for the benefit of all our customers.”